Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $516 - $827
6 Added 10.91%
61 $5,000
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $4,386 - $5,108
-39 Reduced 41.49%
55 $7,000
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $3,016 - $3,564
29 Added 44.62%
94 $10,000
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $5,523 - $7,973
65 New
65 $7,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.